Global anterior uveitis treatment market 2024-2028

PUBLISHED: July 12, 2024

PAGES: 133 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The anterior uveitis treatment market is forecasted to grow by USD 127.8 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the anterior uveitis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing healthcare spending worldwide, development of novel drugs and treatments, and rising cases of anterior uveitis.

Technavio's anterior uveitis treatment market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	4.24%
CAGR	4.5%
Incremental Value	$127.8mn

By Type

Medications
Surgery

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the increasing geriatric population as one of the prime reasons driving the anterior uveitis treatment market growth during the next few years. Also, development of non-steroidal injectables and increasing incidence of optical infections will lead to sizable demand in the market.

The report on the anterior uveitis treatment market covers the following areas:

Anterior uveitis treatment market sizing
Anterior uveitis treatment market forecast
Anterior uveitis treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anterior uveitis treatment market vendors that include AbbVie Inc., Aldeyra Therapeutics Inc, Alimera Sciences Inc., Allergan, American Academy of Ophthalmology, Bausch Lomb Corp., Cadila Pharmaceuticals Ltd., Enzo Biochem Inc., EyePoint Pharmaceuticals Inc, Kiora Pharmaceuticals, Inc., L V PRASAD EYE INSTITUTE, Melinta Therapeutics LLC, Novartis AG, Pfizer Inc., Prometheus Laboratories, Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the anterior uveitis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72239

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Anterior Uveitis Treatment Market 2018 - 2022
- Historic Market Size - Data Table on Global Anterior Uveitis Treatment Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
6.3 Medications - Market size and forecast 2023-2028
- Chart on Medications - Market size and forecast 2023-2028 ($ million)
- Data Table on Medications - Market size and forecast 2023-2028 ($ million)
- Chart on Medications - Year-over-year growth 2023-2028 (%)
- Data Table on Medications - Year-over-year growth 2023-2028 (%)
6.4 Surgery - Market size and forecast 2023-2028
- Chart on Surgery - Market size and forecast 2023-2028 ($ million)
- Data Table on Surgery - Market size and forecast 2023-2028 ($ million)
- Chart on Surgery - Year-over-year growth 2023-2028 (%)
- Data Table on Surgery - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.5 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
8.10 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
8.11 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
- Overview on factors of disruption
10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered
11.2 Market positioning of companies
- Matrix on companies position and classification
11.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
11.4 Alimera Sciences Inc.
- Alimera Sciences Inc. - Overview
- Alimera Sciences Inc. - Product / Service
- Alimera Sciences Inc. - Key offerings
11.5 Bausch Lomb Corp.
- Bausch Lomb Corp. - Overview
- Bausch Lomb Corp. - Business segments
- Bausch Lomb Corp. - Key offerings
- Bausch Lomb Corp. - Segment focus
11.6 Enzo Biochem Inc.
- Enzo Biochem Inc. - Overview
- Enzo Biochem Inc. - Product / Service
- Enzo Biochem Inc. - Key news
- Enzo Biochem Inc. - Key offerings
11.7 EyePoint Pharmaceuticals Inc
- EyePoint Pharmaceuticals Inc - Overview
- EyePoint Pharmaceuticals Inc - Product / Service
- EyePoint Pharmaceuticals Inc - Key offerings
11.8 Kiora Pharmaceuticals, Inc.
- Kiora Pharmaceuticals, Inc. - Overview
- Kiora Pharmaceuticals, Inc. - Product / Service
- Kiora Pharmaceuticals, Inc. - Key offerings
11.9 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
11.10 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
11.11 Santen Pharmaceutical Co. Ltd.
- Santen Pharmaceutical Co. Ltd. - Overview
- Santen Pharmaceutical Co. Ltd. - Product / Service
- Santen Pharmaceutical Co. Ltd. - Key offerings
11.12 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
12.3 Currency conversion rates for US$
- Currency conversion rates for US$
12.4 Research methodology
- Research methodology
12.5 Data procurement
- Information sources
12.6 Data validation
- Data validation
12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
12.8 Data synthesis
- Data synthesis
12.9 360 degree market analysis
- 360 degree market analysis
12.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR72239

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Anterior Uveitis Treatment Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Medications - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Medications - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Medications - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Medications - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Surgery - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Surgery - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Surgery - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Surgery - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits47: Chart on Geographic comparison
Exhibits48: Data Table on Geographic comparison
Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits85: Market opportunity By Geographical Landscape ($ million)
Exhibits86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2023 and 2028
Exhibits88: Overview on criticality of inputs and factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Companies covered
Exhibits92: Matrix on companies position and classification
Exhibits93: AbbVie Inc. - Overview
Exhibits94: AbbVie Inc. - Product / Service
Exhibits95: AbbVie Inc. - Key news
Exhibits96: AbbVie Inc. - Key offerings
Exhibits97: Alimera Sciences Inc. - Overview
Exhibits98: Alimera Sciences Inc. - Product / Service
Exhibits99: Alimera Sciences Inc. - Key offerings
Exhibits100: Bausch Lomb Corp. - Overview
Exhibits101: Bausch Lomb Corp. - Business segments
Exhibits102: Bausch Lomb Corp. - Key offerings
Exhibits103: Bausch Lomb Corp. - Segment focus
Exhibits104: Enzo Biochem Inc. - Overview
Exhibits105: Enzo Biochem Inc. - Product / Service
Exhibits106: Enzo Biochem Inc. - Key news
Exhibits107: Enzo Biochem Inc. - Key offerings
Exhibits108: EyePoint Pharmaceuticals Inc - Overview
Exhibits109: EyePoint Pharmaceuticals Inc - Product / Service
Exhibits110: EyePoint Pharmaceuticals Inc - Key offerings
Exhibits111: Kiora Pharmaceuticals, Inc. - Overview
Exhibits112: Kiora Pharmaceuticals, Inc. - Product / Service
Exhibits113: Kiora Pharmaceuticals, Inc. - Key offerings
Exhibits114: Novartis AG - Overview
Exhibits115: Novartis AG - Business segments
Exhibits116: Novartis AG - Key news
Exhibits117: Novartis AG - Key offerings
Exhibits118: Novartis AG - Segment focus
Exhibits119: Pfizer Inc. - Overview
Exhibits120: Pfizer Inc. - Product / Service
Exhibits121: Pfizer Inc. - Key news
Exhibits122: Pfizer Inc. - Key offerings
Exhibits123: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits124: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibits125: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits126: Viatris Inc. - Overview
Exhibits127: Viatris Inc. - Business segments
Exhibits128: Viatris Inc. - Key news
Exhibits129: Viatris Inc. - Key offerings
Exhibits130: Viatris Inc. - Segment focus
Exhibits131: Inclusions checklist
Exhibits132: Exclusions checklist
Exhibits133: Currency conversion rates for US$
Exhibits134: Research methodology
Exhibits135: Information sources
Exhibits136: Data validation
Exhibits137: Validation techniques employed for market sizing
Exhibits138: Data synthesis
Exhibits139: 360 degree market analysis
Exhibits140: List of abbreviations